Nail disorders in patients with chronic renal failure and undergoing haemodialysis treatment: a case-control study. 2007

P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
Department of Dermatology, Ha'emek Medical Centre, Afula 18101, Israel. pavela4@hotmail.com

BACKGROUND Few controlled studies have compared nail disorders in patients with chronic renal failure (CRF) and haemodialysis (HD)-dependent individuals with a healthy population. OBJECTIVE The aim of this study was to compare the prevalence of nail disorders in patients with CRF and patients undergoing HD treatment with a healthy population, and evaluate the relationship between nail changes and various demographic, medical and laboratory parameters in these groups. METHODS In this case-control study we recruited 73 patients affected with CRF, 77 patients undergoing regular HD and 77 healthy individuals. All patients were examined for the presence of nail disorders. Various parameters [age, gender, type of kidney disease, regular medications, duration of renal failure and HD, dialysis efficacy (Kt/v), haemoglobin, neutrophil count, calcium, phosphorus, albumin, creatinine, urea, alkaline phosphatase and parathyroid hormone (PTH) levels] of the patients were determined by multivariate analysis and compared. RESULTS Forty-four patients (60.3%) with CRF and 48 patients (62.3%) undergoing HD treatment had at least one type of nail pathology. The most common nail alterations found in patients with CRF and those undergoing HD were absence of lunula (AL) and half-and-half nails (HHN), respectively. Prevalence of nail disorders among patients with CRF was influenced significantly by PTH level (P = 0.03). In the HD group, male sex, age above 65 years and comorbidities (diabetes mellitus, hypertension and heart failure) were significantly associated with nail pathologies. CONCLUSIONS Patients with CRF and those undergoing HD therapy have higher rates of nail disorders when compared to a healthy population. Efficient HD does not improve nail changes.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009260 Nail Diseases Diseases of the nail plate and tissues surrounding it. The concept is limited to primates. Disease, Nail,Diseases, Nail,Nail Disease
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
January 2010, Anais brasileiros de dermatologia,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
November 2008, Journal of the European Academy of Dermatology and Venereology : JEADV,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
January 2005, Collegium antropologicum,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
April 1990, The European respiratory journal,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
February 2001, The British journal of dermatology,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
January 1995, Nephron,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
April 1974, Australian and New Zealand journal of medicine,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
February 2004, Journal of the American Academy of Dermatology,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
January 2011, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
P Dyachenko, and A Monselise, and A Shustak, and M Ziv, and D Rozenman
January 1991, Blood purification,
Copied contents to your clipboard!